Resmed Inc. buy Citigroup Inc.
Start price
18.09.25
/
50%
€229.80
Target price
18.09.26
€279.41
Performance (%)
-15.08%
Price
10.04.26
€195.15
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -15.08%. This prediction currently runs until 18.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.412% | 0.412% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
Ratings data for RMD provided by MarketBeat